Several other equities analysts have also recently weighed in on the stock. Needham & Company LLC reiterated a “buy” rating and issued a $15.00 price objective on shares of Invacare in a research note on Wednesday. Zacks Investment Research upgraded shares of Invacare from a “sell” rating to a “hold” rating in a research note on Tuesday, November 5th.
Shares of NYSE IVC traded down $0.56 during trading on Thursday, reaching $10.70. 968,717 shares of the company traded hands, compared to its average volume of 589,246. The firm has a 50 day simple moving average of $7.28 and a 200-day simple moving average of $6.12. The company has a quick ratio of 1.26, a current ratio of 1.90 and a debt-to-equity ratio of 0.83. The stock has a market capitalization of $286.61 million, a PE ratio of -8.11 and a beta of 1.98. Invacare has a 52-week low of $3.05 and a 52-week high of $11.63.
A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Renaissance Technologies LLC raised its stake in Invacare by 85.9% during the second quarter. Renaissance Technologies LLC now owns 1,239,500 shares of the health services provider’s stock worth $6,433,000 after buying an additional 572,800 shares during the last quarter. Stephens Inc. AR raised its stake in Invacare by 1,367.0% during the third quarter. Stephens Inc. AR now owns 293,398 shares of the health services provider’s stock worth $2,200,000 after buying an additional 273,398 shares during the last quarter. River & Mercantile Asset Management LLP bought a new position in Invacare during the second quarter worth $1,233,000. Acadian Asset Management LLC raised its stake in Invacare by 129.4% during the second quarter. Acadian Asset Management LLC now owns 362,135 shares of the health services provider’s stock worth $1,879,000 after buying an additional 204,264 shares during the last quarter. Finally, BlackRock Inc. raised its stake in Invacare by 2.8% during the second quarter. BlackRock Inc. now owns 5,059,730 shares of the health services provider’s stock worth $26,261,000 after buying an additional 138,505 shares during the last quarter.
Invacare Corporation, together with its subsidiaries, designs, manufactures, distributes, and exports medical equipment for use in home health care, retail, and extended care markets worldwide. The company operates through Europe, North America/Home Medical Equipment, Institutional Products Group, and the Asia/Pacific segments.
Recommended Story: Why Invest in Dividend Achievers?
To view ValuEngine’s full report, visit ValuEngine’s official website.
Receive News & Ratings for Invacare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Invacare and related companies with MarketBeat.com's FREE daily email newsletter.